Galmed Pharmaceuticals Ltd. EOCN
3.63
0.01
0.28%
as of 25 Sep
- Market cap
- $3.8M
- P/E
- 0.0×
Follow EOCN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(46.34%) | (64.21%) | (72.12%) | (68.21%) | |
| (40.91%) | (55.53%) | (64.04%) | (55.03%) | ||
ROIC |
(59.29%) | (114.43%) | (94.52%) | (163.19%) | |
Return on Tangible Assets |
(50.43%) | (65.32%) | (79.69%) | (126.78%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(9.20) | (11.72) | (9.33) | (8.97) | |
Free Cash Flow |
(6.28) | (6.31) | (7.68) | (8.54) | |
| Other line items | |||||
Cash ROIC |
(20.43%) | (23.46%) | (35.32%) | (39.44%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.72 | 0.61 | 0.69 | 0.75 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | (0.06) | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(9.20) | (11.72) | (9.33) | (8.97) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates